Timing and clinical outcomes of tracheostomy in patients with COVID-19.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 33640938.
- Also identified by DOI 10.1093/bjs/znaa064 and PMC identifier 7799185.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this retrospective multicentre cohort study that included 27 COVID-19 patients who underwent tracheostomy, the mean time between intubation and tracheostomy was 15.8 days and the negative conversion time of COVID-19 was 43.1 days. Eleven patients (40.7%) died of COVID-19 and the use of percutaneous dilatation tracheostomy was significantly associated with in-hospital death. Timely tracheostomy could be performed in COVID-19 patients, regardless of duration of intubation or positivity of COVID-19 test, with an open surgical tracheostomy as a preferable technique.
Medical subject headings
- COVID-19
- Infectious Disease Transmission, Patient-to-Professional
- Time-to-Treatment
- Tracheostomy